• Open Access

Reasoned opinion on the modification of the existing maximum residues levels (MRLs) for fluazifop-P in several commodities

Authors

  • European Food Safety Authority


  • Correspondence: pesticides.mrl@efsa.europa.eu
  • Approval date: 17 March 2015
  • Published date: 25 March 2015
  • Question number: EFSA-Q-2014-00137
  • On request from: European Commission

Abstract

In accordance with Article 6 of Regulation (EC) No 396/2005, Germany, hereafter referred to as the evaluating Member State (EMS-DE), received an application from LELF to modify the existing MRLs for the active substance fluazifop-P in lupins and linseeds. Afterwards, France, hereafter referred to as the evaluating Member State (EMS-FR), received an application from Syngenta Agro SAS to modify, according to the above regulation, the existing MRLs for fluazifop-P in several commodities, including lupins and linseeds. Amendments of the existing MRLs of fluazifop-P in several vegetables, pulses, oilseeds and in roots of herbal infusions (dried) and roots or rhizome of spices were proposed. Both EMS-DE and EMS-FR drafted evaluation reports in accordance with Article 8 of Regulation (EC) No 396/2005 which were submitted to the European Commission and forwarded to EFSA. According to EFSA, data are sufficient to derive MRL proposals of 0.4 mg/kg on celeriac, 0.5 mg/kg on Jerusalem artichokes, 1.5 mg/kg on peas (without pods), 0.9 mg/kg on globe artichokes, 4 mg/kg on beans, lentils, lupins (pulses), herbal infusions (dried roots) and spices (roots or rhizome), 9 mg/kg on linseeds, poppy seeds and safflower seeds. Adequate analytical enforcement methods are available to control the residues of fluazifop-P in the crops under consideration. Based on the risk assessment results, EFSA concludes that the proposed uses of fluazifop-P on celeriac, Jerusalem artichokes, peas (without pods), globe artichokes, beans, lentils, lupins, linseeds, poppy seeds, safflower seeds, herbal infusions (dried roots) and spices (roots and rhizome) is unlikely to pose a consumer health risk.

Ancillary